Literature DB >> 32011724

Autoantibody Profile of a Cohort of 54 Italian Patients with Linear IgA Bullous Dermatosis: LAD-1 Denoted as a Major Auto-antigen of the Lamina Lucida Subtype.

Emanuele Cozzani1, Giovanni Di Zenzo, Giulia Gasparini, Adele Salemme, Arianna Fay Agnoletti, Camilla Vassallo, Marzia Caproni, Emiliano Antiga, Angelo V Marzano, Riccardo Cavalli, Corrado Ocella, Clara de Simone, Aurora Parodi.   

Abstract

Linear IgA bullous dermatosis (LABD) is characterized by presence of multiple IgA autoantibodies, and a comparatively lesser number of IgG antibodies, directed against different hemidesmosomal antigens. The main autoantigens are LAD-1, LABD-97, BP180 and BP230, type VII collagen and laminin 332. We retrospectively studied the serology of 54 Italian patients with LABD using enzyme-linked immunosorbent assay (ELISA), immunoblotting assay, and indirect immunofluorescence on monkey oesophagus and salt-split skin. Among these, indirect immunofluorescence of salt-split skin elicits the greatest sensitivity. Sixty-three percent of the sera were observed to be positive, with a lamina lucida pattern observed in 48%, a sub-lamina densa pattern in 2% and a mixed pattern in 13% of the cases. IgA reactivity to LAD-1 on immunoblotting was found in 52% of sera, to BP180-NC16A by ELISA in 32% and to BP230 in 26%. Only 17% of patients possessed circulating IgG autoantibodies. LAD-1 was determined to be a major autoantigen of the lamina lucida subtype. Combined serological assays demonstrated a high sensitivity (82%), suggesting that this approach could support diagnosis when a biopsy is not feasible or direct immunofluorescence results are negative.

Entities:  

Keywords:  BP180; BP230; LAD-1; diagnostic sensitivity; humoral immune response; linear IgA bullous disease

Mesh:

Substances:

Year:  2020        PMID: 32011724      PMCID: PMC9128871          DOI: 10.2340/00015555-3415

Source DB:  PubMed          Journal:  Acta Derm Venereol        ISSN: 0001-5555            Impact factor:   3.875


  37 in total

Review 1.  Linear IgA bullous dermatosis.

Authors:  C A Egan; J J Zone
Journal:  Int J Dermatol       Date:  1999-11       Impact factor: 2.736

2.  Identification of the target antigen in chronic bullous disease of childhood and linear IgA disease of adults.

Authors:  F Wojnarowska; P Whitehead; I M Leigh; B S Bhogal; M M Black
Journal:  Br J Dermatol       Date:  1991-02       Impact factor: 9.302

3.  Linear IgA bullous dermatosis with IgA antibodies exclusively directed against the 180- or 230-kDa epidermal antigens.

Authors:  R F Ghohestani; J F Nicolas; J Kanitakis; A Claudy
Journal:  J Invest Dermatol       Date:  1997-06       Impact factor: 8.551

4.  The localization of the target antigens and antibodies in linear IgA disease is heterogeneous, and dependent on the methods used.

Authors:  F Wojnarowska; P M Collier; J Allen; P R Millard
Journal:  Br J Dermatol       Date:  1995-05       Impact factor: 9.302

5.  The shed ectodomain of collagen XVII/BP180 is targeted by autoantibodies in different blistering skin diseases.

Authors:  H Schumann; J Baetge; K Tasanen; F Wojnarowska; H Schäcke; D Zillikens; L Bruckner-Tuderman
Journal:  Am J Pathol       Date:  2000-02       Impact factor: 4.307

6.  IgA antibodies in chronic bullous disease of childhood react with 97 kDa basement membrane zone protein.

Authors:  J J Zone; T B Taylor; D P Kadunce; T P Chorzelski; L A Schachner; J C Huff; L J Meyer; M J Petersen
Journal:  J Invest Dermatol       Date:  1996-06       Impact factor: 8.551

7.  Bullous pemphigoid and linear IgA dermatosis sera recognize a similar 120-kDa keratinocyte collagenous glycoprotein with antigenic cross-reactivity to BP180.

Authors:  H H Pas; G J Kloosterhuis; K Heeres; J B van der Meer; M F Jonkman
Journal:  J Invest Dermatol       Date:  1997-04       Impact factor: 8.551

8.  Immunoblotting studies of linear IgA disease.

Authors:  M Dmochowski; T Hashimoto; B S Bhogal; M M Black; J J Zone; T Nishikawa
Journal:  J Dermatol Sci       Date:  1993-12       Impact factor: 4.563

9.  LAD-1, the linear IgA bullous dermatosis autoantigen, is a novel 120-kDa anchoring filament protein synthesized by epidermal cells.

Authors:  M P Marinkovich; T B Taylor; D R Keene; R E Burgeson; J J Zone
Journal:  J Invest Dermatol       Date:  1996-04       Impact factor: 8.551

Review 10.  Humoral Epitope Spreading in Autoimmune Bullous Diseases.

Authors:  Dario Didona; Giovanni Di Zenzo
Journal:  Front Immunol       Date:  2018-04-17       Impact factor: 7.561

View more
  5 in total

1.  A 62-year-old man with new-onset bullae.

Authors:  August J Generoso; Jordana A Goldman; Alan H Wolff
Journal:  Allergy Asthma Proc       Date:  2021-03-01       Impact factor: 2.587

2.  Linear IGA bullous dermatosis potentially triggered by vaccination.

Authors:  Alberto Corrà; Veronica Bonciolini; Lavinia Quintarelli; Alice Verdelli; Marzia Caproni
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

Review 3.  BP180/Collagen XVII: A Molecular View.

Authors:  Jussi Tuusa; Nina Kokkonen; Kaisa Tasanen
Journal:  Int J Mol Sci       Date:  2021-11-12       Impact factor: 5.923

Review 4.  Type XVII collagen: Relevance of distinct epitopes, complement-independent effects, and association with neurological disorders in pemphigoid disorders.

Authors:  Bianca Opelka; Enno Schmidt; Stephanie Goletz
Journal:  Front Immunol       Date:  2022-08-10       Impact factor: 8.786

Review 5.  Targeting the stem cell niche: role of collagen XVII in skin aging and wound repair.

Authors:  Yangdan Liu; Chiakang Ho; Dongsheng Wen; Jiaming Sun; Lu Huang; Ya Gao; Qingfeng Li; Yifan Zhang
Journal:  Theranostics       Date:  2022-09-06       Impact factor: 11.600

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.